Danish Child Cancer Foundation
12
2
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
8.3%
1 terminated/withdrawn out of 12 trials
75.0%
-11.5% vs industry average
25%
3 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Role: collaborator
Social and Physical Activity as Rehabilitation for Preschool Kids With Cancer
Role: collaborator
Monitoring Neurocognitive Dysfunction and the Impact of Metabolism and Physical Capacity After Paediatric HSCT
Role: collaborator
Rehabilitation Including Structured Active Play for Preschoolers With Cancer.
Role: collaborator
Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia
Role: collaborator
Strength Training as Prevention and Treatment of Late Effects in Long-term Survivors of Pediatric HSCT.
Role: collaborator
Interprofessional Versus Monoprofessional Case-based Learning in Childhood Cancer
Role: collaborator
Thiopurine EnhAnced Maintenance Therapy
Role: collaborator
Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia
Role: collaborator
Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia
Role: collaborator
Prevention of Methotrexate Induced Nephrotoxicity and Prolonged Drug Elimination Time With 12 Hours Prehydration
Role: collaborator
Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses
Role: collaborator
All 12 trials loaded